Pretransfusion Testing and Daratumumab: Assessing Interference Risks and Developing Solutions
Daratumumab is a monoclonal antibody; anti-CD38 is used for the treatment of multiple myeloma and other hematological disorders. Daratumumab, binds to CD 38 on red blood cells (RBCs), interfering with pretransfusion testing. This interference can lead to cross match incompatibility and panreactive i...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer Medknow Publications
2024-05-01
|
| シリーズ: | Global Journal of Transfusion Medicine |
| 主題: | |
| オンライン･アクセス: | https://journals.lww.com/10.4103/gjtm.gjtm_52_23 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|